SavedAdd your journal

Journals / Turkish Journal of Obstetrics and Gynecology / 2018 / Cilt: 15 - Sayı: 3

Active management of the third stage of labor: A brief overview of key issues

Doğumun üçüncü evresinin aktif yönetimi: Kilit konulara kısa bir bakış

Mustafa KOCAER
Kemal GÜNGÖRDÜK
Yusuf OLGAÇ
Varol GÜLSEREN
Pages
188–192
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present current opinion and protocols for AMTSL

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Postpartum hemorrhage is a potentially life-threatening, albeit preventable, condition that persists as a leading cause of maternal death.
📊
Key Findings & Data:It occurs mostlyduring the third stage of labor, and active management of the third stage of labor (AMTSL) can prevent its occurrence.
💡
Conclusion & Impact:Here, we present current opinion and protocols for AMTSL
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Postpartum hemorrhage is a potentially life-threatening, albeit preventable, condition that persists as a leading cause of maternal death. It occurs mostlyduring the third stage of labor, and active management of the third stage of labor (AMTSL) can prevent its occurrence. AMTSL is a recommended series ofsteps, including the provision of uterotonic drugs immediately upon fetal delivery, controlled cord traction, and massage of the uterine fundus, as developedby the World Health Organization. Here, we present current opinion and protocols for AMTSL

Özet

Postpartum kanama, hayatı tehdit eden, önlenebilir bir durumdur, anne ölümünün önde gelen nedenini oluşturan bir durumdur. Çoğunlukla doğumun üçüncü evresi sırasında ortaya çıkar ve doğumun üçüncü evresinin aktif yönetimi (AMTSL) ortaya çıkmasını engelleyebilir. AMTSL, uterotonik ilaçların hemen fetal doğum üzerine uygulanması, kontrollü kordon traksiyonu ve Dünya Sağlık Örgütü tarafından geliştirilen rahim fundus masajı dahil olmak üzere önerilen bir dizi adımdır. Burada AMTSL için güncel görüş ve protokolleri sunuyoruz.

🔖

Cite This Article

KOCAER, M., GÜNGÖRDÜK, K., OLGAÇ, Y., GÜLSEREN, V. (2022). Active management of the third stage of labor: A brief overview of key issues. Turkish Journal of Obstetrics and Gynecology, Cilt: 15 - Sayı: 3, 188–192. https://ajindex.com/articles/613036

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for ObstetricianGynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039-47. Rath WH. Postpartum hemorrhage- update on problems of definitions and diagnosis. Acta Obstet Gynecol Scand 2011:90:421- 28. World Health Organization WHO guidelines for the management of postpartum haemorrhage and retained placenta. Geneva: World Health Organization; 2009. Royal College of Obstetrician and Gynaecologists. Postpartum Hemorrhage: Prevention and Management; 2011.
  2. Zhu C, Estrada M, White J, Lal M. Heat-stable sublingual oxytocin tablets as a potential needle-free approach for preventing postpartum hemorrhage in low-resource settings. Drug Deliv Transl Res 2018;8:853-6.
  3. Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S. Prospective randomized trial of oxytocin administration for active management of the third stage of labor. Int J Gynecol Obstet 2014;127:175-9.
  4. Güngördük K, Asicioglu O, Besimoglu B, Güngördük OC, Yildirm G, Ark C, et al. Using intraumbilical vein injection of oxytocin in routine practice with active management of the third stage of labor: a randomized controlled trial. Obstet Gynecol 2010;116:619-24.
  5. Gohil JT, Tripathi B. A Study to Compare the Efficacy of Misoprostol, Oxytocin, Methyl-ergometrine and Ergometrine-Oxytocin in Reducing Blood Loss in Active Management of 3rd Stage of Labor. J Obstet Gynaecol India 2011;61:408-12.
  6. McDonald SJ, Abbott JM, Higgins SP. Prophylactic ergometrineoxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev 2004:CD000201. Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, et al. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG 2011;118:353-61.
  7. Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-95.
  8. Tuncalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012:CD000494. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva: World Health Organization; 2012.
  9. Tan J, Cao Q, He GL, Cai YH, Yu JJ, Sun X, et al. Misoprostol versus ergometrine-oxytocin for preventing postpartum haemorrhage: a sys